R3 Seminar Series

This seminar was Part 2 of a 2-part webinar series focused on accessing and using biosamples from RECOVER observational studies in ancillary studies. Stay tuned for the recording.

On December 9, 2025, the RECOVER Initiative hosted the first webinar in a two-part series to help researchers use data from the initiative’s observational studies to advance Long COVID research. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID. View the recording on YouTube.

During the October 28 RECOVER Research Review (R3) seminar, RECOVER researchers Samantha Russell, MD, and Janko Nikolich, MD, PhD, MSc, presented their published papers on Long COVID in older adults. Dr. Russell discussed a review article on Long COVID in older adults, which was published in 2024. Dr. Nikolich shared findings from the RECOVER observational study that compared Long COVID symptoms across different age groups. Quinn Barnette, MPH, facilitated the discussion. View the recording on YouTube.

During the RECOVER Research Review (R3) Seminar on October 14, RECOVER researchers Candace Feldman, MD, MPH, ScD, and Kay Rhee, MD, MSc, MA, shared new findings from the initiative’s adult and pediatric observational studies about how social and economic challenges influence the risk of developing Long COVID. RECOVER Representative and coauthor of the adult study paper, Brittany D. Taylor, MPH, joined them to share her experience in collaborating with the paper’s other authors. Elizabeth Karlson, MD, MS, who was also a coauthor of the adult study paper, facilitated the discussion and Q&A session. View the recording on YouTube.

At a recent RECOVER Research Review (R3) Seminar held July 8, RECOVER researchers Rachel Gross, MD, MS; and Tanayott (Tony) Thaweethai, PhD, presented key findings from their study recently published in Journal of the American Medical Association (JAMA) Pediatrics. They were joined by RECOVER Representatives Krista Coombs and Megan Carmilani, who shared personal stories and reflections about the study findings. Amy Salisbury, PhD, RN, FAAN, a coauthor of the publication, facilitated the discussion. View the recording on YouTube.

During a recent RECOVER Research Review (R3) seminar, RECOVER researchers Torri Metz, MD, MS, Chengxi Zang, PhD, and Valerie Flaherman, MD, MPH, shared findings from two major studies examining the risk of developing Long COVID following a SARS-CoV-2 infection during pregnancy. Drawing on data from RECOVER’s observational study of pregnant women and from two national electronic health record (EHR) research networks, these studies represent some of the largest efforts to date exploring the relationship between pregnancy and Long COVID. View the recording on YouTube.

A recent RECOVER Research Review (R3) Seminar held May 13 spotlighted research presented by Carolyn Bramante, MD, MPH (University of Minnesota) and Steve Johnson, PhD (University of Minnesota) exploring how metformin, a widely prescribed medication primarily used to manage type 2 diabetes, may help reduce the risk of Long COVID. The seminar also featured a presentation from Suzanne Vernon, PhD (Bateman Horne Center) on research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a COVID-19 infection. View the recording on YouTube.

During the April 8th RECOVER Research Review (R3) Seminar, RECOVER researchers Hannah Mandel, MS, Fei Wang, PhD, Sandy Preiss, MS, and Abhishek Bhatia, MS presented findings from two different studies of electronic health records (EHRs). Rainu Kaushal, MD (Cornell University), Dr. Wang’s co-author, joined the presenters for the panel discussion and audience Q&A. Both studies examined whether taking the antiviral drug Paxlovid during a COVID-19 infection could help prevent Long COVID. Although Paxlovid is known to reduce the risk of severe COVID-19, there has been limited research into how Paxlovid might impact a person’s risk of developing Long COVID. The studies presented are two of the largest to date that have explored the role of Paxlovid in Long COVID prevention. View the recording on YouTube.

During the March 11th RECOVER Research Review (R3) Seminar, RECOVER researchers shared findings from a recent study that examined how a person’s sex may affect their risk of developing Long COVID. Dimpy Shah, MD, PhD (University of Texas Health Science Center) presented results from the study, and Nora Singer, MD (Case Western Reserve University, MetroHealth Medical Center) shared background about RECOVER’s adult observational study population and ideas for future research in this area. View the recording on YouTube.